BD Pharmingen- PE Mouse Anti-Human IL-1_BD Pharmingen
参考图片
Expression of IL-α by stimulated CD14+ human monocytes. Human PBMCs were stimulated for 6 hours with LPS (10 ng/ml final concentration) in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PBMC were stained with FITC-mouse anti-human CD14 antibody (Clone M5E2, Cat. No. 555397) fixed/permeabilized, and then stained with 0.25 µg of PE-mouse anti-human IL-1α antibody (PE-364-3B3-14, Cat. No. 554561), (left panel). The data reflects gating on monocytes, based on forward and side scatter. To demonstrate specificity of staining, the binding of PE-364-3B3-14 was blocked by preincubation of the PE-364-3B3-14 with a molar excess of recombinant human IL-1α (middle panel), and by the preincubation of the fixed/permeabilized cells with an excess of the unlabeled \"cold\" 364-3B3-14 mouse antibody (5 µg; Cat. No. 551223; right panel). The quadrant markers for the bivariate dot plots were set based on the fixed/permeabilized unstained cell controls, and verified with the recombinant cytokine and \"cold\" antibody specificity controls.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9656.html